Omodenbamab is an anti-SpA (Staplococcal protein A) humanized monoclonal antibody with a KD value of 0.0467 nM. Omodenbamab circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). Omodenbamab can be used in research of S. aureus bloodstream Increased mouse Balb/C mice with MRSA in a bacteremia model survival.
[1]. Varshney AK, et, al. A natural human monoclonal antibody targeting Staplococcus Protein A protects against Staplococcus aureus bacteremia. PLoS One. 2018 Jan 24;13(1):e0190537.
















